Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UK GCA Consortium: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

NCT04102930 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT04102930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UK GCA Consortium: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Lead sponsor
University of Leeds
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2005
Completion date
March 31, 2028
Enrollment
4,500 (estimated)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis, polymyalgia rheumatica